Welcome to LookChem.com Sign In|Join Free

CAS

  • or

40023-86-7

Post Buying Request

40023-86-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40023-86-7 Usage

General Description

1-(3-chlorophenyl)propan-1-amine, also known as 3-CPA, is an organic compound with the molecular formula C9H12ClN. It is classified as a phenethylamine and can act as both a stimulant and a hallucinogen. The compound is a derivative of amphetamine and has a similar chemical structure to other psychoactive substances. 3-CPA is known for its potential to induce feelings of euphoria, increased energy and alertness, and hallucinogenic effects. It has been the subject of research regarding its potential use as a psychoactive drug and its effects on the central nervous system. However, it is important to note that 3-CPA is not approved for medical use and is considered a controlled substance in many countries due to its potential for abuse and addiction.

Check Digit Verification of cas no

The CAS Registry Mumber 40023-86-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,0,2 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 40023-86:
(7*4)+(6*0)+(5*0)+(4*2)+(3*3)+(2*8)+(1*6)=67
67 % 10 = 7
So 40023-86-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H12ClN/c1-2-9(11)7-4-3-5-8(10)6-7/h3-6,9H,2,11H2,1H3

40023-86-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3-Chlorophenyl)propan-1-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:40023-86-7 SDS

40023-86-7Downstream Products

40023-86-7Relevant articles and documents

Kinetic Resolution of Benzylamines via Palladium(II)-Catalyzed C-H Cross-Coupling

Xiao, Kai-Jiong,Chu, Ling,Chen, Gang,Yu, Jin-Quan

, p. 7796 - 7800 (2016/07/06)

A Pd(II)-catalyzed enantioselective C-H cross-coupling of benzylamines via kinetic resolution has been achieved using chiral mono-N-protected α-amino-O-methylhydroxamic acid (MPAHA) ligands. Both chiral benzylamines and ortho-arylated benzylamines are obtained in high enantiomeric purity. The use of a readily removable nosyl (Ns) protected amino group as the directing group is a crucial practical advantage. Moreover, the ortho-arylated benzylamine products could be further transformed into chiral 6-substituted 5,6-dihydrophenanthridines as important structural motifs in natural products and bioactive molecules.

THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS

-

Page/Page column 206-207, (2010/02/12)

Disclosed are novel compounds of Formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of Formula (IA).

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

-

Page 237-238, (2008/06/13)

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40023-86-7